C4 Therapeutics, Inc. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-038587
- Form type
- 10-Q
- CIK
- 0001662579
- Primary document
- https://www.sec.gov/Archives/edgar/data/1662579/000162828025038587/cccc-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for C4 Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $13.7M | - | - |
| Operating Income | $-57.7M | - | - |
| Net Income | $-52.3M | - | - |
| Eps Basic | -0.74 | - | - |
| Eps Diluted | -0.74 | - | - |
| Cash And Equivalents | $78.2M | - | - |
| Total Assets | $296.5M | - | - |
| Total Liabilities | $122.5M | - | - |
| Shareholders Equity | $174.1M | - | - |
| Operating Cash Flow | $-45.3M | - | - |
| Capital Expenditures | $185,000 | - | - |